Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249211142> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4249211142 endingPage "176" @default.
- W4249211142 startingPage "167" @default.
- W4249211142 abstract "Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy Rudolph M NavariIndiana University School of Medicine South Bend, South Bend, IN USAAbstract: Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The emetogenicity of the chemotherapeutic agents, repeated chemotherapy cycles, and patient characteristics (female gender, younger age, low alcohol consumption, history of motion sickness) are the major risk factors for CINV. This review provides a detailed description of palonosetron, a second-generation 5-hydroxytryptamine 3 (5-HT3) receptor antagonist. The chemistry and pharmacology of palonosetron are described, as well as the initial and recent clinical trials. Palonosetron has a longer half-life and a higher binding affinity than the first-generation 5-HT3 receptor antagonists. Palonosetron has been approved for the prevention of acute CINV in patients receiving either moderately or highly emetogenic chemotherapy and for the prevention of delayed CINV in patients receiving moderately emetogenic chemotherapy. In recent studies, compared to the first-generation 5-HT3 receptor antagonists, palonosetron in combination with dexamethasone demonstrated better control of delayed CINV in patients receiving highly emetogenic chemotherapy. There were no clinically relevant adverse reactions reported in the palonosetron clinical trials which were different from the common reactions reported for the 5-HT3 receptor antagonist class. Due to its efficacy in controlling both acute and delayed CINV, palonosetron may be very effective in the clinical setting of multiple-day chemotherapy and bone marrow transplantation.Keywords: anti-emetics, chemotherapy-induced nausea and vomiting, serotonin receptor antagonists, palonosetron" @default.
- W4249211142 created "2022-05-12" @default.
- W4249211142 creator A5076594436 @default.
- W4249211142 date "2009-12-01" @default.
- W4249211142 modified "2023-09-26" @default.
- W4249211142 title "Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy" @default.
- W4249211142 doi "https://doi.org/10.2147/cmar.s6460" @default.
- W4249211142 hasPublicationYear "2009" @default.
- W4249211142 type Work @default.
- W4249211142 citedByCount "7" @default.
- W4249211142 countsByYear W42492111422016 @default.
- W4249211142 countsByYear W42492111422018 @default.
- W4249211142 countsByYear W42492111422019 @default.
- W4249211142 countsByYear W42492111422021 @default.
- W4249211142 countsByYear W42492111422023 @default.
- W4249211142 crossrefType "journal-article" @default.
- W4249211142 hasAuthorship W4249211142A5076594436 @default.
- W4249211142 hasBestOaLocation W42492111421 @default.
- W4249211142 hasConcept C126322002 @default.
- W4249211142 hasConcept C143998085 @default.
- W4249211142 hasConcept C2776694085 @default.
- W4249211142 hasConcept C2776712918 @default.
- W4249211142 hasConcept C2777452722 @default.
- W4249211142 hasConcept C2779924295 @default.
- W4249211142 hasConcept C2780580376 @default.
- W4249211142 hasConcept C2780852908 @default.
- W4249211142 hasConcept C2780884295 @default.
- W4249211142 hasConcept C42219234 @default.
- W4249211142 hasConcept C71924100 @default.
- W4249211142 hasConcept C98274493 @default.
- W4249211142 hasConceptScore W4249211142C126322002 @default.
- W4249211142 hasConceptScore W4249211142C143998085 @default.
- W4249211142 hasConceptScore W4249211142C2776694085 @default.
- W4249211142 hasConceptScore W4249211142C2776712918 @default.
- W4249211142 hasConceptScore W4249211142C2777452722 @default.
- W4249211142 hasConceptScore W4249211142C2779924295 @default.
- W4249211142 hasConceptScore W4249211142C2780580376 @default.
- W4249211142 hasConceptScore W4249211142C2780852908 @default.
- W4249211142 hasConceptScore W4249211142C2780884295 @default.
- W4249211142 hasConceptScore W4249211142C42219234 @default.
- W4249211142 hasConceptScore W4249211142C71924100 @default.
- W4249211142 hasConceptScore W4249211142C98274493 @default.
- W4249211142 hasLocation W42492111421 @default.
- W4249211142 hasOpenAccess W4249211142 @default.
- W4249211142 hasPrimaryLocation W42492111421 @default.
- W4249211142 hasRelatedWork W100286279 @default.
- W4249211142 hasRelatedWork W2052445101 @default.
- W4249211142 hasRelatedWork W2071699340 @default.
- W4249211142 hasRelatedWork W2085651211 @default.
- W4249211142 hasRelatedWork W2099365808 @default.
- W4249211142 hasRelatedWork W2121534313 @default.
- W4249211142 hasRelatedWork W2993010168 @default.
- W4249211142 hasRelatedWork W3026792217 @default.
- W4249211142 hasRelatedWork W4245250147 @default.
- W4249211142 hasRelatedWork W2616177214 @default.
- W4249211142 hasVolume "Volume 1" @default.
- W4249211142 isParatext "false" @default.
- W4249211142 isRetracted "false" @default.
- W4249211142 workType "article" @default.